{"id":"https://openalex.org/W7124464347","doi":"https://doi.org/10.5463/thesis.1577","title":"Exploiting microRNAs as circulating biomarkers and regulators of key targetable proteins to combat cancer chemoresistance","display_name":"Exploiting microRNAs as circulating biomarkers and regulators of key targetable proteins to combat cancer chemoresistance","publication_year":2026,"publication_date":"2026-01-17","ids":{"openalex":"https://openalex.org/W7124464347","doi":"https://doi.org/10.5463/thesis.1577"},"language":"en","primary_location":{"id":"doi:10.5463/thesis.1577","doi":"https://doi.org/10.5463/thesis.1577","is_oa":true,"landing_page_url":"https://doi.org/10.5463/thesis.1577","pdf_url":null,"source":null,"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vrije Universiteit Amsterdam","raw_type":"dissertation"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.5463/thesis.1577","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043933789","display_name":"Mahrou Vahabi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Mahrou Vahabi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5043933789"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10773","display_name":"Extracellular vesicles in disease","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10515","display_name":"Cancer-related molecular mechanisms research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.9869999885559082},{"id":"https://openalex.org/keywords/cancer-chemoresistance","display_name":"cancer chemotherapy resistance","score":0.9110000133514404},{"id":"https://openalex.org/keywords/circulating-biomarkers","display_name":"circulating biomarkers","score":0.9850000143051147},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9160000085830688},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.972000002861023},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":1.0},{"id":"https://openalex.org/keywords/mir-96-5p","display_name":"miR-96-5p","score":0.8960000276565552},{"id":"https://openalex.org/keywords/extracellular-vesicles","display_name":"extracellular vesicles","score":0.9300000071525574},{"id":"https://openalex.org/keywords/mir-200-family","display_name":"miR-200 family","score":0.875},{"id":"https://openalex.org/keywords/gemcitabine-resistance","display_name":"gemcitabine resistance","score":0.9459999799728394},{"id":"https://openalex.org/keywords/tivantinib","display_name":"tivantinib","score":0.8370000123977661},{"id":"https://openalex.org/keywords/c-met-inhibition","display_name":"c-Met inhibition","score":0.8700000047683716},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.843999981880188},{"id":"https://openalex.org/keywords/nucleoside-analogue-resistance","display_name":"nucleoside analogue resistance","score":0.8230000138282776},{"id":"https://openalex.org/keywords/radiotherapy-resistance","display_name":"radiotherapy resistance","score":0.5979999899864197},{"id":"https://openalex.org/keywords/microrna-therapy","display_name":"miRNA-based therapy","score":0.5899999737739563}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.7152000069618225},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.6947000026702881},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5902000069618225},{"id":"https://openalex.org/C2777148230","wikidata":"https://www.wikidata.org/wiki/Q17144959","display_name":"FOLFIRINOX","level":5,"score":0.5720000267028809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5690000057220459},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.483599990606308},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.48159998655319214},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.47450000047683716},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.46389999985694885},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4625000059604645},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.4185999929904938},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.4034000039100647},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.390500009059906},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.37290000915527344},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.34360000491142273},{"id":"https://openalex.org/C2992026798","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic ductal adenocarcinoma","level":4,"score":0.2989000082015991},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.29420000314712524},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2874999940395355},{"id":"https://openalex.org/C2777002142","wikidata":"https://www.wikidata.org/wiki/Q5031432","display_name":"Cancer biomarkers","level":3,"score":0.2854999899864197},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.28200000524520874},{"id":"https://openalex.org/C2994294914","wikidata":"https://www.wikidata.org/wiki/Q1645075","display_name":"Acquired resistance","level":3,"score":0.26019999384880066},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26010000705718994},{"id":"https://openalex.org/C2778384578","wikidata":"https://www.wikidata.org/wiki/Q16930687","display_name":"Therapeutic approach","level":3,"score":0.25949999690055847},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C20518536","wikidata":"https://www.wikidata.org/wiki/Q6840469","display_name":"Microvesicles","level":4,"score":0.25609999895095825}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.5463/thesis.1577","doi":"https://doi.org/10.5463/thesis.1577","is_oa":true,"landing_page_url":"https://doi.org/10.5463/thesis.1577","pdf_url":null,"source":null,"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vrije Universiteit Amsterdam","raw_type":"dissertation"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/e9766175-df58-4cfd-846e-b393a5aaf75d","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/e9766175-df58-4cfd-846e-b393a5aaf75d","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vahabi, M 2026, 'Exploiting microRNAs as circulating biomarkers and regulators of key targetable proteins to combat cancer chemoresistance', Doctor of Philosophy, Vrije Universiteit Amsterdam. https://doi.org/10.5463/thesis.1577","raw_type":"info:eu-repo/semantics/other"},{"id":"pmh:oai:research.vu.nl:openaire/ad00d899-3006-4b12-a484-facbeaf8f471","doi":null,"is_oa":true,"landing_page_url":"https://research.vu.nl/en/publications/ad00d899-3006-4b12-a484-facbeaf8f471","pdf_url":null,"source":{"id":"https://openalex.org/S4306401107","display_name":"VU Research Portal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I865915315","host_organization_name":"Vrije Universiteit Amsterdam","host_organization_lineage":["https://openalex.org/I865915315"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Vahabi, M 2026, 'Exploiting microRNAs as circulating biomarkers and regulators of key targetable proteins to combat cancer chemoresistance', PhD, Vrije Universiteit Amsterdam. https://doi.org/10.5463/thesis.1577","raw_type":"book"}],"best_oa_location":{"id":"doi:10.5463/thesis.1577","doi":"https://doi.org/10.5463/thesis.1577","is_oa":true,"landing_page_url":"https://doi.org/10.5463/thesis.1577","pdf_url":null,"source":null,"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Vrije Universiteit Amsterdam","raw_type":"dissertation"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2165837717","https://openalex.org/W2766884278","https://openalex.org/W4309691594","https://openalex.org/W3031632466","https://openalex.org/W2182375217","https://openalex.org/W2196795346","https://openalex.org/W2163006881","https://openalex.org/W4200286235","https://openalex.org/W2570371485","https://openalex.org/W2102271390"],"abstract_inverted_index":{"The":[0],"limited":[1],"availability":[2],"of":[3,41,56,64,104,126,149,203],"effective":[4],"treatments":[5],"and":[6,24,43,70,77,82,92,114,130,137,144,153,168,185,192,243],"the":[7,17,36,39,54,62,101,123,147,200,231,236],"generally":[8],"poor":[9],"prognosis":[10],"associated":[11],"with":[12,209],"many":[13],"cancer":[14,96,223,242],"types":[15],"highlight":[16],"pressing":[18],"need":[19],"for":[20,219],"novel":[21,120,160],"therapeutic":[22,115,154,195,201,249],"approaches":[23,245],"new":[25],"directions":[26],"in":[27,67,80,106,112,128,146,173,181,187,211,240],"chemoresistance":[28,42],"research.":[29],"Accordingly,":[30],"this":[31,59],"thesis":[32],"aims":[33],"to":[34,44,52,133,135,183,235,246],"elucidate":[35],"mechanisms":[37,232],"driving":[38],"development":[40],"identify":[45],"potential":[46,73,172,202],"vulnerabilities":[47],"that":[48,224],"may":[49],"be":[50],"exploited":[51],"improve":[53,247],"effectiveness":[55],"chemotherapy.":[57],"Specifically,":[58],"work":[60],"examines":[61,193,230],"role":[63,125],"microRNAs":[65,179],"(miRNAs)":[66],"therapy":[68],"resistance":[69,134,182,234],"evaluates":[71,169],"their":[72,110,170],"as":[74,151],"diagnostic,":[75],"prognostic,":[76],"predictive":[78],"biomarkers":[79],"head":[81],"neck":[83],"squamous":[84],"cell":[85,94,221],"carcinoma":[86],"(HNSCC),":[87],"pancreatic":[88,188],"ductal":[89,189],"adenocarcinoma":[90,190],"(PDAC),":[91],"non-small":[93],"lung":[95,222,241],"(NSCLC).":[97],"Chapter":[98,117,139,157,175,197,213,228],"2":[99],"reviews":[100,141,215],"current":[102],"knowledge":[103],"miRNAs":[105],"HNSCC,":[107],"focusing":[108],"on":[109,122,162,178],"roles":[111],"tumorigenesis":[113],"potential.":[116],"3":[118],"reports":[119,159],"findings":[121,161],"oncogenic":[124],"miR-96-5p":[127],"HNSCC":[129],"its":[131,248],"contribution":[132],"chemotherapy":[136],"radiotherapy.":[138],"4":[140],"recent":[142],"advances":[143],"challenges":[145],"use":[148],"EVs":[150],"biomarker":[152],"delivery":[155],"systems.":[156],"5":[158],"plasma-derived":[163],"EV":[164],"miR-200":[165],"family":[166],"members":[167],"diagnostic":[171],"PDAC.":[174,212],"6":[176],"focuses":[177],"implicated":[180],"gemcitabine":[184,210],"FOLFIRINOX":[186],"(PDAC)":[191],"miRNA-based":[194],"approaches.":[196],"7":[198],"investigates":[199],"combining":[204],"tivantinib,":[205],"a":[206],"c-MET":[207],"inhibitor,":[208],"8":[214],"emerging":[216],"treatment":[217],"strategies":[218],"small":[220],"extend":[225],"beyond":[226],"immunotherapy.":[227],"9":[229],"underlying":[233],"nucleoside":[237],"analog":[238],"RX-3117":[239],"proposes":[244],"efficacy.":[250]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2026-01-17T00:00:00"}